Houari Omar, Douanla Arnaud, Ben Ammar Mehdi, Benmekhbi Mustapha, Mortada Jihad, Lungu Gabriel, Magheru Cristian, Voirin Jimmy, Lebedinsky Pablo Ariel, Musacchio Mariano, Bolognini Federico, Srour Robin
Department of Neurosurgery, Hôpitaux Civils de Colmar, Colmar, France.
Department of Diagnostic and Interventional Neuroradiology, Hôpitaux Civils de Colmar, Colmar, France.
Clin Spine Surg. 2025 Jun 1;38(5):E269-E276. doi: 10.1097/BSD.0000000000001704. Epub 2024 Oct 15.
Hybrid retrospective/prospective study.
The study evaluated the long-term safety and efficacy of the FFX facet cage versus pedicle screw (PS) fixation in patients with lumbar spinal stenosis (LSS).
A previous single-arm study reported on the safety, fusion rate, and patient outcomes associated with the use of the FFX facet cage in patients with lumbar spinal stenosis. There are no long-term studies reporting outcomes with this device compared with the use of pedicle screw fixation.
Following a medical records review, subjects meeting the inclusion and exclusion criteria were consented to and enrolled in the prospective arm of the study. CT scans and dynamic X-rays were performed to assess fusion rates, range of motion, and translation. Adverse events during the 2-year post-index procedure were also analyzed. Preoperative and 2+ year Visual Analogue Scale (VAS) back and leg scores and Oswestry Disability Index (ODI) were also obtained.
A total of 112 subjects were enrolled with 56 patients included in the PS and FFX groups. Mean age was 63.1±11.2 and 67.1±10.9 years and the mean number of levels operated was 1.8±0.8 and 2.3±1.0, respectively, for the PS and FFX groups. There was no difference between the 2 groups for the primary composite fusion endpoint assessed with the FFX group achieving a 91% bony facet fusion rate. There was also no difference in postoperative complications or adverse events during the 2-year follow-up period. A higher percentage of patients in the PS group (10.7%) required reoperation compared with the FFX group (3.6%). Although both groups experienced significant improvements in VAS and ODI scores versus preoperative assessment, there was no difference between the 2 groups.
The present study documents the long-term safety and efficacy of the FFX device in patients with LSS with a reduction in reoperation rate when compared with PS fixation.
Level III.
回顾性与前瞻性混合研究。
本研究评估了FFX椎间融合器与椎弓根螺钉(PS)固定术治疗腰椎管狭窄症(LSS)患者的长期安全性和有效性。
此前一项单臂研究报告了FFX椎间融合器在腰椎管狭窄症患者中的安全性、融合率及患者预后情况。尚无长期研究报告该器械与椎弓根螺钉固定术相比的治疗结果。
在回顾病历后,符合纳入和排除标准的受试者签署知情同意书并纳入研究的前瞻性队列。进行CT扫描和动态X线检查以评估融合率、活动度和移位情况。还分析了索引手术后2年内的不良事件。同时获取术前及术后2年以上的视觉模拟评分(VAS)背部和腿部评分以及奥斯威斯利功能障碍指数(ODI)。
共纳入112名受试者,PS组和FFX组各56例患者。PS组和FFX组的平均年龄分别为63.1±11.2岁和67.1±10.9岁,平均手术节段数分别为1.8±0.8和2.3±1.0。在评估的主要复合融合终点方面,两组之间无差异,FFX组的骨小关节融合率达到91%。在2年随访期内,术后并发症或不良事件也无差异。与FFX组(3.6%)相比,PS组需要再次手术的患者比例更高(10.7%)。尽管两组的VAS和ODI评分与术前评估相比均有显著改善,但两组之间无差异。
本研究证明了FFX器械治疗LSS患者的长期安全性和有效性,与PS固定术相比,再次手术率有所降低。
三级。